Oberheiden Law Group | |
To date, more than 2,600 plaintiffs have filed claims alleging serious medical conditions resulting from inadequate warnings. This includes a substantial number of Ozempic cases filed against Novo Nordisk. These lawsuits argue that Novo Nordisk either was aware or should have been aware of various undisclosed risks for hospital admission linked to Ozempic, and they seek compensation for plaintiffs’ medical costs, lost wages, emotional distress, and other financial and non-financial losses. Currently, the national GLP-1 MDL (or the “Ozempic MDL”) is in the discovery phase. This means that plaintiffs’ legal teams are in the process of gathering the evidence they need to prove that Novo Nordisk and the other defendants deserve to be held accountable. Through the discovery process, plaintiffs’ legal teams are gaining access to the defendants’ internal records—to find out what they knew and when—and they are also working with healthcare providers and other members of the medical community to demonstrate that plaintiffs’ use of the defendants’ GLP-1 weight loss mediations resulted in an increased risk of serious side effects such as gastroparesis and NAION. ![]() | |
Related Link: Click here to visit item owner's website (0 hit) | |
Target State: Arizona Target City : Phoenix Last Update : Oct 15, 2025 1:42 AM Number of Views: 10 | Item Owner : Oberheiden Law Group Contact Email: Contact Phone: (None) |
Friendly reminder: Click here to read some tips. |